: The AT2 receptor is a developmentally regulated receptor that is up-regulated in adult cardiovascular tissues in response to injury. This receptor exerts growth inhibitory action on vascular smooth muscle cell (VSMC) in part via the activation of phosphotyrosine phosphatase and the inactivation of MAP kinase (ERK). We have shown that in PC12W cells and in VSMC, MKP-1 plays a critical role in the MAP kinase inactivation. The importance of AT2 receptor expression in the developmental biology of VSMC has been demonstrated in vitro and in vivo. Indeed, we demonstrated that cultured VSMC derived from AT2 receptor knock out mice at embryonic day 20 exhibits an exaggerated growth response to growth factors even in the absence of Ang II. Moreover, we showed that ERK plays a central role in this response. Taken together, these data suggest that the AT2 receptor expression influences fetal vasculogenesis via the programming of ERK cascade and subsequently the expression of growth modulating genes. The purpose of this proposal is to elucidate and identify, using genome technology, the genes whose expression are pivotal to AT2 receptor's action on growth modulation and development of VSMC. We expect to discover genes that play global and generalized roles in VSMC growth and development.
Our specific aims are: 1) To employ gene array technologies to discover and characterize the genes whose expression are differentially regulated in neonatal VSMC derived from wild type and AT2 knockout mouse aorta. 2) To further identify the subject of those genes that are regulated by the ERK cascade. This will be accomplished by studying gene expression in above VSMC in the presence or absence of inhibitors of ERK pathway. 3) To use high throughput in vitro screening assays for cell proliferation and cell death to identify the function of the novel genes discovered in Aim 2. This will be accomplished by a gain of function (gene transfer) or loss of function (antisense) approaches. 4) To characterize expression patterns of these genes vivo during development and in vascular injury, and 5) to define the in vivo function of these novel genes with the production of recombinant mice.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058516-10
Application #
6895200
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Lin, Michael
Project Start
1997-09-01
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2007-08-31
Support Year
10
Fiscal Year
2005
Total Cost
$429,132
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Matsushita, Kenichi; Wu, Yaojiong; Pratt, Richard E et al. (2016) Deletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b/beta-catenin signaling. Lab Invest 96:909-17
Matsushita, Kenichi; Morello, Fulvio; Zhang, Zhiping et al. (2016) Nuclear hormone receptor LXR? inhibits adipocyte differentiation of mesenchymal stem cells with Wnt/beta-catenin signaling. Lab Invest 96:230-8
Matsushita, Kenichi; Morello, Fulvio; Wu, Yaojiong et al. (2010) Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha. J Biol Chem 285:11974-82
Zhang, Zhiping; Dzau, Victor J (2010) Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance. Hypertension 55:1086-7
He, Wei; Zhang, Lunan; Ni, Aiguo et al. (2010) Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A 107:21110-5
Gnecchi, Massimiliano; He, Huamei; Melo, Luis G et al. (2009) Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 27:971-9
Zhang, Zhongyan; Deb, Arjun; Zhang, Zhiping et al. (2009) Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol 46:370-7
Hirsch, Jan; Hansen, Kirk C; Sapru, Anil et al. (2007) Impact of low and high tidal volumes on the rat alveolar epithelial type II cell proteome. Am J Respir Crit Care Med 175:1006-13
Ip, James E; Wu, Yaojiong; Huang, Jing et al. (2007) Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell 18:2873-82
Matsushita, Kenichi; Wu, Yaojiong; Okamoto, Yoshihisa et al. (2006) Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 48:1095-102

Showing the most recent 10 out of 49 publications